(B) Cleaved caspase 3 immunofluorescence of tumor sections reveals elevated apoptosis, a sign of increased sensitivity of ISR-null SCC tumors to proteotoxic stress (bortezomib treatment 1.2 mg/kg i.p. on days 13, 15, and 17). Here, CASP3 is linked to neoplasm.